{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 96,
  "pageCount": 239,
  "prevPage": 95,
  "nextPage": 97,
  "slideType": "testimonial",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses highlighted text to emphasize key negative performance metrics and qualitative feedback.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/96",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-96",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "He states that he didn’t have a single back/leg pain patient who made it past a year, and that only 2 out of 90 patients he implanted with Nevro still have the device – an explant rate approaching 100%.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33e-066eda8461a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "explant rate: 100%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33e-0d4eed391981",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.88,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Case study #2: A high volume implanter and KOL who was also initially impressed with Nevro's data, only to see patients fail \"like clockwork\" within 3-6 months. He states that he didn't have a single back/leg pain patient who made it past a year, and that only 2 out of 90 patients he implanted with Nevro still have the device – an explant rate approaching 100%. He added that \"a lot, a lot of doctors\" have had the same experience with a \"70-80% explant rate.\" Similar to the first case study, the KOL emphasized that his explant rate with other companies' stimulators is negligible.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c8d07e95-8fe0-4b5d-bea5-7ae8fedf3ee0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.72
      },
      "kind": "quote",
      "text": "\"A third of my explants were because the device sucks. The device stops working - call that the reason a third or fifty percent of the time. The vast majority of my explants were because the device stopped working. The remainder were because of the rep not being able to program it. If the leads move even a little bit the Nevro reps get lost and they don't know where to program because there's no buzzing or tingling, no paresthesia. So they don't know what to do. They're programming blind.\" - High volume implanter and KOL",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6eeb510d-8b1c-4e3a-bc3e-c81bdccd3aca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.88,
        "x": 0.06,
        "y": 0.55
      },
      "kind": "quote",
      "text": "\"The patients' pain just came back. It was pretty consistent. It was between three to six months almost across the board, or if not then by 8 months. I didn't have a single patient that made it past a year except for the ones with abdominal pain. Every other patient - like every one of them - I might have 2 back patients that still have it out of 90 I implanted with Nevro. That's not unheard of. There are a lot, a lot, of doctors who have had that experience. I know of a lot of doctors who had a 70-80% explant rate. My overall explant rate is very low. No one can say that my Nevro explants were due to my patient selection\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7ace8ee-f19d-4465-904f-2b7835b7630b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.41
      },
      "kind": "quote",
      "text": "\"But then the failures just kept coming. People just kept getting explanted or the pain just kept coming back. I used to use Nevro for just about everything, like low back pain, leg pain, and neck pain. But after three to six months it was like clockwork that patients just started shitting the bed. So I just stopped using it. In 2016 and 2017 Nevro was 40% of my implant volume and then a drop in 2018 and 2019. I've only used two Nevro devices this year.\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca0719da-93b8-40fc-af91-07f9b242eabc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.88,
        "x": 0.06,
        "y": 0.33
      },
      "kind": "quote",
      "text": "\"When Nevro launched in 2015, I was really interested in the data and how much better it worked than regular spinal cord stimulation. So I used it and I was very impressed with it in the beginning.\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d73fca77-1e3e-414a-ae52-66c011c4f21d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“When Nevro launched in 2015, I was really interested in the data and how much better it worked than regular spinal cord stimulation. So I used it and I was very impressed with it in the beginning.” — High volume implanter and KOL",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33e-09092cc22531",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.06,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "de56ea6d-dde8-4a52-8170-cd48b8a3b4a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.75,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be31d777-c038-4ccd-b12d-d44a866b8a68",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d32cf136-2cc4-4bd9-8b67-28f675029de8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}